The molecular basis of NleB mediated bacterial virulence
Bacterial pathogens have evolved distinct ways of colonizing host cells and promote infection. Many human intestinal bacterial pathogens such as Salmonella, Shigella and enteropathogenic/ enterohemorrhagic Escherichia coli utilize...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CAMPY SECRETION
Comparative Proteomics and Function of Secreted Proteins of...
45K€
Cerrado
INFBIOSYS
THE ROLE OF BACTERIAL MULTIGENE FAMILIES IN INFECTION IDENT...
173K€
Cerrado
BURK-6
Investigation of the Type VI secretion system associated tox...
276K€
Cerrado
BIO2013-49148-C2-1-R
REGULACION DE LA VIRULENCIA BACTERIANA POR PROTEINAS QUE REC...
182K€
Cerrado
BIO2013-49148-C2-2-R
REGULACION DE LA VIRULENCIA BACTERIANA POR PROTEINAS QUE REC...
121K€
Cerrado
BIO2016-80329-P
GLICANOS Y TEMPERATURA COMO MODULADORES DE LA VIRULENCIA EN...
290K€
Cerrado
Información proyecto BATTLE
Duración del proyecto: 33 meses
Fecha Inicio: 2015-03-23
Fecha Fin: 2018-01-03
Líder del proyecto
UNIVERSITY OF DUNDEE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
183K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Bacterial pathogens have evolved distinct ways of colonizing host cells and promote infection. Many human intestinal bacterial pathogens such as Salmonella, Shigella and enteropathogenic/ enterohemorrhagic Escherichia coli utilize type III secretion systems to deliver virulence effector proteins into the host to promote colonization and interfere with antimicrobial host response. Among the type III effectors, the NleB protein has been shown to be essential for virulence of enteric pathogens. NleB is a glycosyltransferase that has been shown to interact with host cell death-domain-containing proteins, GlcNAcylate a specific arginine on these and thereby inhibiting death receptor signalling and preventing host cell apoptosis. This proposal will 1) investigate how NleB specifically recognises the host death domains, 2) uncover the molecular mechanisms of arginine GlcNAcylation, 3) explain how death domain GlcNAcylation prevents the death domain from binding to its receptor, and 4) exploit this molecular information to generate bisubstrate inhibitors to interfere with this process.